Company enters into an exclusive distribution agreement for Switzerland, covering all products in the Bactiguard Infection Protection portfolio
Swedish medtech company Bactiguard has increased its presence in Europe by entering into an exclusive distribution agreement for Switzerland, covering all products in the Bactiguard Infection Protection portfolio.
‘We are delighted about our expansion in Switzerland, a market recognised for its high quality healthcare. We have managed to break into one of Europe's toughest markets, which strengthens the brand and our market position in Europe,’ says Johan Rugfelt, CEO.
In Switzerland, with a population of 8 million people, almost 11% of its GDP is spent on healthcare. The overall prevalence of healthcare associated infections (HAI) is approximately 11%. As in the rest of the world, HAI and multi-resistant bacteria are a major challenge. Implementing preventive measures, such as Bactiguard’s catheters for the urinary and respiratory tract, and the bloodstream, is therefore essential to tackle this severe problem.
The Swiss distributor, GD Medical, is a family owned company based in Freienbach. The company has been marketing and distributing equipment for surgery, intensive care and diagnostics and other medical devices since 2006.
‘Switzerland provides high quality healthcare and is at the forefront of implementing innovations. The need for preventive solutions to combat healthcare associated infections is high and we are looking forward to selling Bactiguard’s high technology products, increasing patient safety and saving money for the healthcare system,’ said Gabriel Dürst, CEO, GD Medical.